Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

Compare

12.32

-0.23 (-1.83%)

At close: Feb 4, 2026, 4:00 PM EST

12.08

-0.24 (-1.95%)

After-hours: Feb 4, 2026, 4:59 PM EST

Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	58.34	69.53	66.39	59.97	142.75	28.38
Short-Term Investments	94.47	188.39	270.5	306.17	342.51	161.94
Cash & Short-Term Investments	152.81	257.92	336.89	366.13	485.26	190.32
Cash Growth	-47.90%	-23.44%	-7.99%	-24.55%	154.97%	370.80%
Receivables	-	-	-	2	2	2
Prepaid Expenses	10.54	8.43	8.8	6.57	4.52	1.31
Restricted Cash	0.43	-	0.86	0.57	0.57	-
Total Current Assets	163.78	266.34	346.54	375.27	492.34	193.63
Property, Plant & Equipment	43.93	47.58	53.42	57.77	6.09	11.3
Other Long-Term Assets	2.43	2.57	2.61	3.43	1.73	2.32
Total Assets	210.14	316.49	402.57	436.47	500.16	207.25
Accounts Payable	2.23	1.6	2.79	4.45	3.23	1.84
Accrued Expenses	11.38	14.76	14.11	16.23	9.22	5.35
Current Portion of Leases	3.1	2.45	2.08	1.77	1.5	0.96
Current Income Taxes Payable	-	-	-	0.04	0.05	-
Current Unearned Revenue	-	17.62	25.67	31.79	26.02	31.98
Other Current Liabilities	1.73	1.74	1.29	1.27	0.67	0.79
Total Current Liabilities	18.44	38.17	45.94	55.55	40.69	40.92
Long-Term Leases	31.66	34.04	36.84	39.36	-	6.93
Long-Term Unearned Revenue	-	44.77	66.68	92.09	114.72	120.81
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	50.11	116.98	149.46	186.99	155.41	168.65
Common Stock	0.11	0.11	0.1	0.09	0.09	0.04
Additional Paid-In Capital	724.2	700.63	624.08	522.61	506.76	141.64
Retained Earnings	-564.4	-501.56	-371.26	-269.51	-161.34	-103.1
Comprehensive Income & Other	0.12	0.34	0.19	-3.71	-0.77	0.02
Total Common Equity	160.03	199.52	253.11	249.48	344.75	38.6
Shareholders' Equity	160.03	199.52	253.11	249.48	344.75	38.6
Total Liabilities & Equity	210.14	316.49	402.57	436.47	500.16	207.25
Total Debt	34.76	36.49	38.92	41.13	1.5	7.88
Net Cash (Debt)	118.05	221.42	297.97	325	483.75	182.44
Net Cash Growth	-53.83%	-25.69%	-8.32%	-32.82%	165.16%	472.15%
Net Cash Per Share	1.07	2.03	3.15	3.70	7.79	5.71
Filing Date Shares Outstanding	134.59	108.11	106.72	88.2	87.71	14.2
Total Common Shares Outstanding	111.57	107.73	102.2	88.18	87.6	13.3
Working Capital	145.34	228.17	300.6	319.73	451.65	152.72
Book Value Per Share	1.43	1.85	2.48	2.83	3.94	2.90
Tangible Book Value	160.03	199.52	253.11	249.48	344.75	38.6
Tangible Book Value Per Share	1.43	1.85	2.48	2.83	3.94	2.90
Machinery	13.56	13.32	12.88	11.65	6.25	5.14
Construction In Progress	-	0.15	0.04	0.01	0.74	-
Leasehold Improvements	3.72	2.87	2.86	2.78	0.25	0.25

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q